News & Updates

Exposure to azithromycin may put patients with COVID‐19 and history of cardiovascular disease (CVD) at higher risks of acute heart failure and death, as reported in a study.

Use of theophylline as an adjunctive therapy appears to lead to favourable outcomes among patients with bradycardia due to acute spinal cord injury (SCI) with an acceptable response to this agent, suggest the results of a study.

Among individuals with type 2 diabetes (T2D), the risk of poor outcomes such as heart failure and hospitalizations is high in the presence of advanced liver fibrosis, according to a study.

Treatment with sodium-glucose lowering co-transporter 2 inhibitors (SGLT2i) helps arrest the decline in estimated glomerular filtration rate (eGFR) and is associated with a lower risk of adverse kidney events among adults with diabetes, irrespective of baseline albuminuria status, as shown in a study presented at the recent ADA 2023.

Shared decision making should be practiced by clinicians to include patient preferences and values when taking into account the duration of anticoagulant therapy for unprovoked venous thromboembolism (VTE), suggests a study.

A cuffless wearable device may help improve hypertension management if it demonstrates accuracy and clinical utility. However, a recent study has found that a commercially available blood pressure (BP) monitoring device does not accurately track night-time BP decline and medication-induced BP changes.

The presence of sleep hypertension modifies the sleep-related factors associated with masked hypertension, according to a study.